|
Kenneth F. Buechler, Ph.D., is President, Chief Scientific Officer and co-founder of Biosite Incorporated. Dr. Buechler is a co-inventor of certain Biosite proprietary technologies, including the Triage Drugs of Abuse Panel and the Triage Meter Plus platform.
From 1988 to 1994, Dr. Buechler was Biosite’s Director of Chemistry. Prior to forming Biosite, Dr. Buechler was a senior research scientist for the Diagnostics Research and Development Group at Hybritech Incorporated in San Diego. As a Senior Research Scientist, he was responsible for new product development and was the transfer project leader for ICON® QSR CK-MB, a cardiac marker assay. In addition, he was responsible for the design and synthesis of reagents for use in the first rapid, visual pregnancy test, the ICON® hCG test.
Dr. Buechler received his doctorate in biochemistry and his bachelor’s degree in chemistry from Indiana University. He is a member of the American Chemical Society, the Biochemical Society, the International Federation of Clinical Chemistry and Laboratory Medicine and the American Association of Clinical Chemists. | 